Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T02:07:21.435Z Has data issue: false hasContentIssue false

Deanol in Depression

A Controlled Trial

Published online by Cambridge University Press:  08 February 2018

J. Dominian*
Affiliation:
The Bethlem Royal Hospital and The Maudsley Hospital
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The management of mild depression and its concomitant associated symptoms of general debility presents a constant and widespread challenge to psychiatry both in hospital and in general practice. It is inevitable that at some stage resort will be made to drugs. This is a tempting pharmacological field and the level of interest is indicated by the available plethora of alternatives. A recently introduced drug in current use and purported to be of use specifically in this field is Deanol (Deaner) which is the p-acetamidobenzoic acid salt of 2-dimethyl-aminoethanol or Atrol which is the bitartrate of the same base.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1960 
Submit a response

eLetters

No eLetters have been published for this article.